Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07392476 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring in Polycystic Ovarian Syndrome
A clinical trial of Polycystic Ovarian Syndrome (PCOS), sponsored by The Cleveland Clinic.
- Active
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07392476: Active study of Polycystic Ovarian Syndrome (PCOS), sponsored by The Cleveland Clinic.
NCT07392476 is a study of Polycystic Ovarian Syndrome (PCOS) that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07392476, a study of Polycystic Ovarian Syndrome (PCOS), is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome. The patient will be asked to wear a continuous glucose monitor (CGM) device that is applied to the arm with a sensor or filament that goes under the skin to measure your sugar levels. The patient will wear this at certain time points throughout the study. There will have a total of 2 blood draws (about 1 tsp. of blood) at screening and the 6-month visit, a measure of the patients body muscle and fat (body composition), and fill out a questionnaire at the end of the first 3 months and 6 months. Study participation in the research will last about 6 months.
Primary Outcome
To describe CGM-derived glucometrics in patients with PCOS before and after lifestyle modification and/or pharmacologic intervention.
Conditions Studied
Interventions
- DEVICE Stelo glucose biosensor by Dexcom
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-12-24 |
| Est. Completion | 2027-08-15 |
What the registry record for NCT07392476 still lists
NCT07392476 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 1 condition, with Polycystic Ovarian Syndrome (PCOS) appearing as the primary indexed condition, and to 1 intervention - of which Stelo glucose biosensor by Dexcom is the first listed.
NCT07392476 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07392476 about?
NCT07392476 is a clinical study titled "Continuous Glucose Monitoring in Polycystic Ovarian Syndrome". The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome. The patient will be asked to wear a continuous glucose monitor (CGM) device that is applied to the arm with a sensor or filament that goes under the skin to measure your sugar levels. The patient wi...
What is the current status of trial NCT07392476?
This trial is currently active not recruiting. The enrollment target is 40 participants. The study started on 2025-12-24. Estimated completion is 2027-08-15.
What conditions does trial NCT07392476 study?
This clinical trial studies the following conditions: Polycystic Ovarian Syndrome (PCOS).
What interventions are being tested in trial NCT07392476?
The interventions under investigation include: Stelo glucose biosensor by Dexcom (DEVICE).
Who is sponsoring clinical trial NCT07392476?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07392476 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI